Q1 2017 Aratana Therapeutics Inc Earnings Call
Conference Call Aratana Therapeutics Inc
Aratana Therapeutics Inc Conference call or earnings call will be held on May 9, 2017 During the earnings conference call's session Aratana Therapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Aratana Therapeutics Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. We operate in one business segment, which sits at the intersection of the more than $60 billion annual U.S. pet market and the more than $23 billion annual worldwide animal health market. Cats and dogs are the most popular pet species in the United States and Europe: there are approximately 86 million cats and 78 million dogs in the United States and 99 million cats and 81 million dogs in Europe. An estimated 68% of households in the United States have at least one pet. We believe that the role of pets in the family has significantly evolved over the last two decades. Many pet owners consider pets important members of their families, and they have been increasingly willing to spend money to maintain the health of their pets.Read more Conference Call